Брилинта таб 90 мг 56 шт

Brilinta®, used concomitantly with acetylsalicylic acid, is indicated for the prevention of atherothrombotic events in patients with acute coronary syndrome (unstable angina, non-ST-segment elevation myocardial infarction or ST-segment elevation myocardial infarction [STEMI]), including patients receiving drug therapy, and patients undergoing percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG).

Contraindications

Hypersensitivity to ticagrelor or any of the components of the drug; Active pathological bleeding; History of intracranial hemorrhage; Severe liver failure; Concomitant use of ticagrelor with strong CYP3A4 inhibitors (for example, ketoconazole, clarithromycin, nefazodone, ritonavir and atazanavir); Children under 18 years of age (due to the lack of data on the effectiveness and safety of use in this group of patients); Pregnancy and breastfeeding period.

Пульмикорт 0.5мг/мл-2мл №20

Budesonide, an inhaled glucocorticosteroid, in recommended doses has an anti-inflammatory effect in the bronchi, reducing the severity of symptoms and the frequency of exacerbations of bronchial asthma with a lower incidence of side effects than when using systemic glucocorticosteroids. Reduces the severity of edema of the bronchial mucosa, mucus production, sputum formation and airway hyperreactivity. It is well tolerated during long-term treatment and does not have mineralocorticosteroid activity.

Clinical studies – bronchial asthma

The effectiveness of Pulmicort® has been assessed in numerous studies. The drug has been shown to be effective in the treatment of persistent asthma in both adults and children when used once or twice daily. Inhaled budesonide has also been shown to be effective in treating and preventing exacerbations of asthma in children and adults.

Пульмикорт 0.25мг/мл-2мл №20

Budesonide, an inhaled glucocorticosteroid, in recommended doses has an anti-inflammatory effect in the bronchi, reducing the severity of symptoms and the frequency of exacerbations of bronchial asthma with a lower incidence of side effects than when using systemic glucocorticosteroids. Reduces the severity of edema of the bronchial mucosa, mucus production, sputum formation and airway hyperreactivity. It is well tolerated during long-term treatment and does not have mineralocorticosteroid activity.

Clinical studies – bronchial asthma

The effectiveness of Pulmicort® has been assessed in numerous studies. The drug has been shown to be effective in the treatment of persistent asthma in both adults and children when used once or twice daily. Inhaled budesonide has also been shown to be effective in treating and preventing exacerbations of asthma in children and adults.

Symbicort Turbohaler 160/4.5

Bronchial asthma

Symbicort Turbuhaler, 160 mcg/4.5 mcg, is prescribed to adults and children over 12 years of age for the regular treatment of bronchial asthma when it is advisable to use combination therapy (inhaled corticosteroid and long-acting β2-adrenergic receptor agonist):

Chronic obstructive pulmonary disease

Symbicort Turbuhaler is indicated for the symptomatic treatment of adult patients over the age of 18 years with COPD with a forced expiratory volume in 1 second (FEV1) < 70% of predicted normal (after use of a bronchodilator) and a history of exacerbations, despite regular use.

Symbicort Turbohaler 80/4.5

Bronchial asthma

Symbicort Turbuhaler, 80 mcg/4.5 mcg, is prescribed to adults and children over 12 years of age for the regular treatment of bronchial asthma when it is advisable to use combination therapy (inhaled corticosteroid and long-acting β2-adrenergic receptor agonist):

Chronic obstructive pulmonary disease

Symbicort Turbuhaler is indicated for the symptomatic treatment of adult patients over the age of 18 years with COPD with a forced expiratory volume in 1 second (FEV1) < 70% of predicted normal (after use of a bronchodilator) and a history of exacerbations, despite regular use.

$180.85$350.99

6

Syndicate customized growth strategies prospective human capital leverage other's optimal e-markets without transparent catalysts for change. Credibly coordinate highly efficient methods of empowerment cross unit solutions.

$180.85$350.99

7

Syndicate customized growth strategies prospective human capital leverage other's optimal e-markets without transparent catalysts for change. Credibly coordinate highly efficient methods of empowerment cross unit solutions.

$180.85$350.99

8

Syndicate customized growth strategies prospective human capital leverage other's optimal e-markets without transparent catalysts for change. Credibly coordinate highly efficient methods of empowerment cross unit solutions.

$180.85$350.99

9

Syndicate customized growth strategies prospective human capital leverage other's optimal e-markets without transparent catalysts for change. Credibly coordinate highly efficient methods of empowerment cross unit solutions.

$180.85$350.99

10

Syndicate customized growth strategies prospective human capital leverage other's optimal e-markets without transparent catalysts for change. Credibly coordinate highly efficient methods of empowerment cross unit solutions.

$180.85$350.99

11

Syndicate customized growth strategies prospective human capital leverage other's optimal e-markets without transparent catalysts for change. Credibly coordinate highly efficient methods of empowerment cross unit solutions.

$180.85$350.99

12

Syndicate customized growth strategies prospective human capital leverage other's optimal e-markets without transparent catalysts for change. Credibly coordinate highly efficient methods of empowerment cross unit solutions.

$180.85$350.99

13

Syndicate customized growth strategies prospective human capital leverage other's optimal e-markets without transparent catalysts for change. Credibly coordinate highly efficient methods of empowerment cross unit solutions.

$180.85$350.99

14

Syndicate customized growth strategies prospective human capital leverage other's optimal e-markets without transparent catalysts for change. Credibly coordinate highly efficient methods of empowerment cross unit solutions.

$180.85$350.99

Gaming Computer

Syndicate customized growth strategies prospective human capital leverage other's optimal e-markets without transparent catalysts for change. Credibly coordinate highly efficient methods of empowerment cross unit solutions.

$180.85$350.99

Gaming Computer

Syndicate customized growth strategies prospective human capital leverage other's optimal e-markets without transparent catalysts for change. Credibly coordinate highly efficient methods of empowerment cross unit solutions.